2m 2m 2m 2m 2m 2m 2m
Editas Medicine (EDIT)
NASDAQ
$2.63+$0.04 (+1.74%)
Price as of Aug 03, 2026 9:14 AM EDT- $395.9MMarket Cap
- 5.74%1-Year Change
- BiotechnologyIndustry
Editas Medicine (EDIT)
$2.63+$0.04 (+1.74%)
EDIT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.58 | ||
Change | -$0.11 (-4.09%) | ||
Open | $2.67 | ||
High | $2.70 | ||
Low | $2.53 | ||
Previous Close | $2.69 | ||
Volume | 1,180,097 | ||
30-Day Average Volume | 1,981,983 | ||
1-Week Change | -0.77% | ||
1-Month Change | -20.37% | ||
1-Year Change | 5.74% | ||
3-Year Change | -70.62% | ||
5-Year Change | -93.84% | ||
Fundamentals | |||
Shares Outstanding | 153.5M | ||
Total Assets | $149.3M | ||
Market Cap | $395.9M | ||
Enterprise Value | $327.0M | ||
Period: QTR TTM FY | |||
Revenue | $2.8M | ||
Net Income | -$25.0M | ||
Free Cash Flow | -$23.2M | ||
EBIT | -$23.9M | ||
EBITDA | -$23.4M | ||
Net Working Capital | $88.3M | ||
EPS | -$0.26 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | 115 | ||
P/B | 90 | ||
P/E | -10 | ||
PEG | 0 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue